Neurotrophic Keratopathy Withdrawn Phase 2 / 3 Trials for Insulin human (DB00030)
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0077055 (Neurotrophic Keratopathy) | Withdrawn | 2 / 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05321251 | Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy. | Treatment |